Physician profile
Robert K Mcgregor
NPI 1285042861
$346.46
in general payments reported to CMS, 2019-2025
9 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.91 · 2023: $67.13 · 2024: $35.60 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $144.42 | 2025 | Korlym |
| Insmed, INC. | $50.84 | 2023 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.63 | 2023-2024 | Ofev |
| Abbvie INC. | $31.46 | 2024-2025 | |
| Lilly USA, LLC | $20.06 | 2025 | Zepbound, Mounjaro |
| Acella Pharmaceuticals, LLC | $19.76 | 2025 | NP Thyroid 60 |
| Intra-Sana Laboratories | $17.47 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Tolmar, INC. | $14.91 | 2025 | Jatenzo |
| Janssen Pharmaceuticals, INC | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcgregor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.